Posterior pituitary tumors and other rare entities involving the pituitary gland.
atypical teratoid rhabdoid tumor
pituicytoma
pituitary
primary papillary epithelial tumor of the sella
sella
thyroid transcription factor 1
Journal
Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781
Informations de publication
Date de publication:
30 Sep 2024
30 Sep 2024
Historique:
received:
02
08
2024
accepted:
04
09
2024
medline:
1
10
2024
pubmed:
1
10
2024
entrez:
1
10
2024
Statut:
aheadofprint
Résumé
Non-neuroendocrine tumors account for around 10% of all primary neoplasms of the sella. If meningiomas, craniopharyngiomas, and germ cell tumors are excluded, the remaining lesions include a broad spectrum of uncommon, benign, and aggressive, often diagnostically challenging lesions. This review aims to summarize the essential clinicopathological features of tumors of the posterior pituitary gland, infundibulum spectrum expressing thyroid transcription factor 1, and primary sellar atypical rhabdoid teratoid tumor, and provide the criteria for their diagnosis and management.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13307Informations de copyright
© 2024 The Author(s). Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
Références
Castellanos LE, Gutierrez C, Smith T, Laws ER, Iorgulescu JB. Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification. Pituitary. 2022;25(1):201–209. https://doi.org/10.1007/s11102-021-01189-6
Brat DJ, Wesseling P, Lopes MBS, et al. Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma. Central nervous system tumours. WHO classification of tumours series [Internet]. Volume 6. 5th ed. Lyon: International Agency for Research on Cancer; 2021 [cited 2024 Jun 29]. Available from: https://tumourclassification.iarc.who.int/chapters/45
Lee EB, Tihan T, Scheithauer BW, Zhang PJ, Gonatas NK. Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol. 2009;68(5):482–488. https://doi.org/10.1097/NEN.0b013e3181a13fca
Takei Y, Seyama S, Pearl GS, Tindall GT. Ultrastructural study of the human neurohypophysis. II. Cellular elements of neural parenchyma, the pituicytes. Cell Tissue Res. 1980;205(2):273–287.
Mete O, Lopes MB, Asa SL. Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol. 2013;37(11):1694–1699. https://doi.org/10.1097/PAS.0b013e31829723e7
Asa SL, Osamura RY, Mete O. Pituitary tumours. Endocrine and neuroendocrine tumours. WHO classification of tumours series [Internet]. Volume 10. 5th ed. Lyon: International Agency for Research on Cancer; 2022 [cited 2024 Jun 29]. Available from: https://tumourclassification.iarc.who.int/chapters/53
Osamura RY, Mete O, Perry A. Pituicytomas. Endocrine and neuroendocrine tumours. WHO classification of tumours series [Internet]. Volume 10. 5th ed. Lyon: International Agency for Research on Cancer; 2022 [cited 2024 Jun 29]. Available from: https://tumourclassification.iarc.who.int/chapters/53
Schmid S, Solomon DA, Perez E, Thieme A, Kleinschmidt‐DeMasters BK, Giannini C, et al. Genetic and epigenetic characterization of posterior pituitary tumors. Acta Neuropathol. 2021;142(6):1025–1043. https://doi.org/10.1007/s00401-021-02377-1
Mio C, Baldan F, Damante G. NK2 homeobox gene cluster: functions and roles in human diseases. Genes Dis. 2022;10(5):2038–2048. https://doi.org/10.1016/j.gendis.2022.10.001
Guan L, Zhao X, Tang L, Chen J, Zhao J, Guo M, et al. Thyroid transcription factor‐1: structure, expression, function and its relationship with disease. Biomed Res Int. 2021;2021:9957209. https://doi.org/10.1155/2021/9957209
Fernández LP, López‐Márquez A, Santisteban P. Thyroid transcription factors in development, differentiation and disease. Nat Rev Endocrinol. 2015;11(1):29–42. https://doi.org/10.1038/nrendo.2014.186
Ordóñez NG. Value of thyroid transcription factor‐1 immunostaining in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol. 2012;20(5):429–444. https://doi.org/10.1097/PAI.0b013e31825439bc
Galloway M, Sim R. TTF‐1 staining in glioblastoma multiforme. Virchows Arch. 2007;451(1):109–111. https://doi.org/10.1007/s00428-007-0432-5
Suwala AK, Stichel D, Schrimpf D, Maas SLN, Sill M, Dohmen H, et al. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy‐number profile with inactivation of TP53, PTEN, and RB1. Acta Neuropathol. 2021;142(1):179–189. https://doi.org/10.1007/s00401-021-02302-6
Yohan Alexander A, Michalopoulos G, Kerezoudis P, Van Gompel JJ, Link MJ, Peris‐Celda M. Treatment modalities and outcomes of granular cell tumors and spindle cell oncocytomas of the pituitary gland: an analysis of two national cancer databases. Acta Neurochir. 2024;166(1):169 [Erratum in: Acta Neurochir 2024;166(1):187]. https://doi.org/10.1007/s00701-024-06054-6
Samadian M, Mousavinejad SA, Khoshsirat S, Dehghan M, Sharifi G, Ebrahimzadeh K, et al. Trans‐nasal trans‐sphenoidal endoscopic resection of spindle cell oncocytoma of adenohypophysis: the first case report in a child and a review of literature. Asian J Neurosurg. 2020;15(1):210–213. https://doi.org/10.4103/ajns.AJNS_166_19
Whipple SG, Savardekar AR, Rao S, Mahadevan A, Guthikonda B, Kosty JA. Primary tumors of the posterior pituitary gland: a systematic review of the literature in light of the new 2017 World Health Organization classification of pituitary tumors. World Neurosurg. 2021;145:148–158. https://doi.org/10.1016/j.wneu.2020.09.023
Guerrero‐Pérez F, Marengo AP, Vidal N, Iglesias P, Villabona C. Primary tumors of the posterior pituitary: a systematic review. Rev Endocr Metab Disord. 2019;20(2):219–238. https://doi.org/10.1007/s11154-019-09484-1
Guerrero‐Pérez F, Vidal N, Marengo AP, Pozo CD, Blanco C, Rivero‐Celada D, et al. Posterior pituitary tumours: the spectrum of a unique entity. A clinical and histological study of a large case series. Endocrine. 2019;63(1):36–43. https://doi.org/10.1007/s12020-018-1774-2
Iglesias P, Guerrero‐Pérez F, Villabona C, Díez JJ. Adenohypophyseal hyperfunction syndromes and posterior pituitary tumors: prevalence, clinical characteristics, and pathophysiological mechanisms. Endocrine. 2020;70(1):15–23. https://doi.org/10.1007/s12020-020-02399-x
Marco Del Pont F, Villalonga JF, Ries‐Centeno T, Arakaki N, Katz D, Cervio A. Pituicytoma associated with acromegaly and Cushing disease. World Neurosurg. 2020;136:78–82. https://doi.org/10.1016/j.wneu.2019.12.085
Schmalisch K, Schittenhelm J, Ebner FH, Beuschlein F, Honegger J, Beschorner R. Pituicytoma in a patient with Cushing's disease: case report and review of the literature. Pituitary. 2012;15(Suppl 1):S10–S16. https://doi.org/10.1007/s11102-010-0262-3
Covington MF, Chin SS, Osborn AG. Pituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta‐analysis of the world literature since 1893. AJNR Am J Neuroradiol. 2011;32(11):2067–2072. https://doi.org/10.3174/ajnr.A2717
Atila C, Refardt J, Christ‐Crain M. Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency. Nat Rev Endocrinol. 2024;20(8):487–500. https://doi.org/10.1038/s41574-024-00985-x
Billeci D, Marton E, Giordan E, Carraro V, Ronzon M, Rossi S. Spindle cell oncocytoma: report of two cases with massive bleeding and review of the literature. J Clin Neurosci. 2017;39:39–44. https://doi.org/10.1016/j.jocn.2017.02.017
Fujisawa H, Tohma Y, Muramatsu N, Kida S, Kaizaki Y, Tamamura H. Spindle cell oncocytoma of the adenohypophysis with marked hypervascularity. Case Report Neurol Med Chir. 2012;52(8):594–598. https://doi.org/10.2176/nmc.52.594
Hasegawa H, Van Gompel JJ, Oushy SH, Pollock BE, Link MJ, Meyer FB, et al. A comprehensive study of spindle cell oncocytoma of the pituitary gland: series of 6 cases and meta‐analysis of 85 cases. World Neurosurg. 2021;149:e197–e216. https://doi.org/10.1016/j.wneu.2021.02.051
Osman M, Wild A. Spindle cell oncocytoma of the anterior pituitary presenting with an acute clinical course due to intraventricular hemorrhage. A case report and review of literature. Am J Case Rep. 2017;17(18):894–901. https://doi.org/10.12659/ajcr.903702
Hammoud DA, Munter FM, Brat DJ, Pomper MG. Magnetic resonance imaging features of pituicytomas: analysis of 10 cases. J Comput Assist Tomogr. 2010;34(5):757–761. https://doi.org/10.1097/RCT.0b013e3181e289c0
Ogiwara H, Dubner S, Shafizadeh S, Raizer J, Chandler JP. Spindle cell oncocytoma of the pituitary and pituicytoma: two tumors mimicking pituitary adenoma. Surg Neurol Int. 2011;2:116. https://doi.org/10.4103/2152-7806.83932
Cole TS, Potla S, Sarris CE, Przybylowski CJ, Baranoski JF, Mooney MA, et al. Rare thyroid transcription factor 1‐positive tumors of the sellar region: Barrow Neurological Institute retrospective case series. World Neurosurg. 2019;129:e294–e302. https://doi.org/10.1016/j.wneu.2019.05.132
Li Y, Chen SH, Sheinberg D, Buttrick S, Levine CG, Bhatia RG, et al. Imaging characteristics of a Hypervascular pituitary spindle cell oncocytoma on magnetic resonance imaging and digital subtraction angiography. World Neurosurg. 2020;133:56–59. https://doi.org/10.1016/j.wneu.2019.09.108
Hasiloglu ZI, Ure E, Comunoglu N, Tanriover N, Oz B, Gazioglu N, et al. New radiological clues in the diagnosis of spindle cell oncocytoma of the adenohypophysis. Clin Radiol. 2016;71(9):937.e5–937.e11. https://doi.org/10.1016/j.crad.2016.04.022
Ahmed AK, Dawood HY, Penn DL, Smith TR. Extent of surgical resection and tumor size predicts prognosis in granular cell tumor of the sellar region. Acta Neurochir. 2017;159(11):2209–2216. https://doi.org/10.1007/s00701-017-3337-3
Giantini Larsen AM, Cote DJ, Zaidi HA, Bi WL, Schmitt PJ, Iorgulescu JB, et al. Spindle cell oncocytoma of the pituitary gland. J Neurosurg. 2018;131(2):517–525. https://doi.org/10.3171/2018.4.JNS18211
Tariciotti L, Arrichiello A, Fiore G, Bertani G, Conte G, Paolucci A, et al. Arterial embolization and second‐look in spindle cell oncocytoma of the pituitary gland: case report and review of literature. World Neurosurg. 2020;142:87–92. https://doi.org/10.1016/j.wneu.2020.05.255
Chainey J, Chan VK, Au K, Das S. Multiple recurrences of spindle cell oncocytoma: a case report and literature review. Clin Neuropathol. 2020;39(1):32–39. https://doi.org/10.5414/NP301209
Coiré CI, Horvath E, Smyth HS, Kovacs K. Rapidly recurring folliculostellate cell tumor of the adenohypophysis with the morphology of a spindle cell oncocytoma: case report with electron microscopic studies. Clin Neuropathol. 2009;28(4):303–308. https://doi.org/10.5414/npp28303
Kloub O, Perry A, Tu PH, Lipper M, Lopes MB. Spindle cell oncocytoma of the adenohypophysis: report of two recurrent cases. Am J Surg Pathol. 2005;29(2):247–253. https://doi.org/10.1097/01.pas.0000147400.87767.f6
Manoranjan B, Koziarz A, Kameda‐Smith MM, Provias JP. Multiple recurrences require long‐term follow‐up in patients diagnosed with spindle cell oncocytoma of the sella turcica. J Clin Neurosci. 2017;43:134–146. https://doi.org/10.1016/j.jocn.2017.05.017
Das L, Vaiphei K, Rai A, Ahuja CK, Singh P, Mohapatra I, et al. Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence. Endocr Connect. 2021;10(4):387–400. https://doi.org/10.1530/EC-20-0621
Borg A, Jaunmuktane Z, Dorward N. Tumors of the neurohypophysis: one unit's experience and literature review. World Neurosurg. 2020;134:e968–e978. https://doi.org/10.1016/j.wneu.2019.11.043
Scothorne CM. A glioma of the posterior lobe of the pituitary gland. J Pathol Bacteriol. 1955;69(1‐2):109–112. https://doi.org/10.1002/path.1700690115
Brat DJ, Scheithauer BW, Staugaitis SM, Holtzman RN, Morgello S, Burger PC. Pituicytoma: a distinctive low‐grade glioma of the neurohypophysis. Am J Surg Pathol. 2000;24(3):362–368. https://doi.org/10.1097/00000478-200003000-00004
Goodman AL, Velázquez Vega JE, Rey Martinez LC, Brat DJ, Schniederjan MJ. Epithelioid pituicytoma: expanding the morphologic spectrum of a rare neoplasm. J Neuropathol Exp Neurol. 2020;79(12):1376–1378. https://doi.org/10.1093/jnen/nlaa076
Hagel C, Buslei R, Buchfelder M, Fahlbusch R, Bergmann M, Giese A, et al. Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells. Pituitary. 2017;20(2):211–217. https://doi.org/10.1007/s11102-016-0762-x
Viaene AN, Lee EB, Rosenbaum JN, Nasrallah IM, Nasrallah MP. Histologic, immunohistochemical, and molecular features of pituicytomas and atypical pituicytomas. Acta Neuropathol Commun. 2019;7(1):69. https://doi.org/10.1186/s40478-019-0722-6
Wang J, Liu Z, Du J, Cui Y, Fang J, Xu L, et al. The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma. Neuropathology. 2016;36(5):432–440. https://doi.org/10.1111/neup.12291
Cao Y, Zeng Y, Qin X, Tan Y, Zeng M, Wang L, et al. A rare case report of pituicytoma with biphasic pattern and admixed with scattered herring bodies. World J Surg Oncol. 2020;18(1):108. https://doi.org/10.1186/s12957-020-01889-6
Kwon MJ, Suh YL. Pituicytoma with unusual histological features. Pathol Int. 2011;61(10):598–602. https://doi.org/10.1111/j.1440-1827.2011.02708.x
Takei H, Goodman JC, Tanaka S, Bhattacharjee MB, Bahrami A, Powell SZ. Pituicytoma incidentally found at autopsy. Pathol Int. 2005;55(11):745–749. https://doi.org/10.1111/j.1440-1827.2005.01890.x
Ulm AJ, Yachnis AT, Brat DJ, Rhoton AL Jr. Pituicytoma: report of two cases and clues regarding histogenesis. Neurosurgery. 2004;54(3):753–757 [discussion 757–8; Erratum in: Neurosurgery. 2004;54(5):1252]. https://doi.org/10.1227/01.neu.0000108983.50966.b7
Roncaroli F, Scheithauer BW, Cenacchi G, Horvath E, Kovacs K, Lloyd RV, et al. ‘Spindle cell oncocytoma’ of the adenohypophysis: a tumor of folliculostellate cells? Am J Surg Pathol. 2002;26(8):1048–1055. https://doi.org/10.1097/00000478-200208000-00010
Soukup J, Kasparova P, Kohout A, Rychly B, Skarkova V, Syrucek M, et al. Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary. Pituitary. 2019;22(1):70–78. https://doi.org/10.1007/s11102-018-00935-7
El Hussein S, Vincentelli C. Pituicytoma: review of commonalities and distinguishing features among TTF‐1 positive tumors of the central nervous system. Ann Diagn Pathol. 2017;29:57–61. https://doi.org/10.1016/j.anndiagpath.2017.05.004
Kong X, Li D, Kong Y, Zhong D. Malignant adenohypophysis spindle cell oncocytoma with repeating recurrences and a high Ki‐67 index. Medicine. 2017;96(4):e5657. https://doi.org/10.1097/MD.0000000000005657
Guadagno E, Cervasio M, Di Somma A, Califano M, Solari D, Del Basso De Caro M. Essential role of ultrastructural examination for spindle cell oncocytoma: case report of a rare neoplasm and review of the literature. Ultrastruct Pathol. 2016;40(2):121–124. https://doi.org/10.3109/01913123.2016.1157662
Pratt D, Mehta GU, Wang HW, Chittiboina P, Quezado M. A 47‐year old female with a destructive sellar mass. Brain Pathol. 2017;27(2):241–242. https://doi.org/10.1111/bpa.12491
Dahiya S, Sarkar C, Hedley‐Whyte ET, Sharma MC, Zervas NT, Sridhar E, et al. Spindle cell oncocytoma of the adenohypophysis: report of two cases. Acta Neuropathol. 2005;110(1):97–99. https://doi.org/10.1007/s00401-005-1009-5
Kisiel M, Reddy KKV, Provias J, Whitton AC, Lu JQ. Spindle cell oncocytoma reclassified from amelanotic melanocytoma of the sellar region. Clin Neuropathol. 2023;42(5):197–200. https://doi.org/10.5414/NP301550
Cohen‐Gadol AA, Pichelmann MA, Link MJ, Scheithauer BW, Krecke KN, Young WF Jr, et al. Granular cell tumor of the sellar and suprasellar region: clinicopathologic study of 11 cases and literature review. Mayo Clin Proc. 2003;78(5):567–573. https://doi.org/10.4065/78.5.567
Kasashima S, Oda Y, Nozaki J, Shirasaki M, Nakanishi I. A case of atypical granular cell tumor of the neurohypophysis. Pathol Int. 2000;50(7):568–573. https://doi.org/10.1046/j.1440-1827.2000.01080.x
Shuangshoti S, Chantra K, Navalitloha Y, Charoonwatanalaoha S, Shuangshoti S. Atypical granular cell tumor of the neurohypophysis: a case report with review of the literature. J Med Assoc Thai. 1998;81(8):641–646.
Scheithauer BW, Swearingen B, Whyte ET, Auluck PK, Stemmer‐Rachamimov AO. Ependymoma of the sella turcica: a variant of pituicytoma. Hum Pathol. 2009;40(3):435–440. https://doi.org/10.1016/j.humpath.2008.08.013
Lee JS, Cho KH, Hong EK, Shin SH. Pituitary ependymoma, 10‐year follow‐up after partial resection and radiation therapy. Brain Tumor Res Treat. 2017;5(2):94–98. https://doi.org/10.14791/btrt.2017.5.2.94
Mukhida K, Asa S, Gentili F, Shannon P. Ependymoma of the pituitary fossa. Case report and review of the literature. J Neurosurg. 2006;105(4):616–620. https://doi.org/10.3171/jns.2006.105.4.616
Zhao L, Jiang Y, Wang Y, Bai Y, Liu L, Li Y. Case report: sellar ependymomas: a clinic‐pathological study and literature review. Front Endocrinol. 2021;12:551493 [Erratum in: Front Endocrinol. 2021;12:748952]. https://doi.org/10.3389/fendo.2021.551493
Saeed Kamil Z, Sinson G, Gucer H, Asa SL, Mete O. TTF‐1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma. Endocr Pathol. 2014;25(4):436–438. https://doi.org/10.1007/s12022-013-9279-2
Vajtai I, Beck J, Kappeler A, Hewer E. Spindle cell oncocytoma of the pituitary gland with follicle‐like component: organotypic differentiation to support its origin from folliculo‐stellate cells. Acta Neuropathol. 2011;122(2):253–258. https://doi.org/10.1007/s00401-011-0835-x
Yoshimoto T, Takahashi‐Fujigasaki J, Inoshita N, Fukuhara N, Nishioka H, Yamada S. TTF‐1‐positive oncocytic sellar tumor with follicle formation/ependymal differentiation: non‐adenomatous tumor capable of two different interpretations as a pituicytoma or a spindle cell oncocytoma. Brain Tumor Pathol. 2015;32(3):221–227. https://doi.org/10.1007/s10014-015-0219-3
Schöning JV, Flitsch J, Lüdecke DK, Fahlbusch R, Buchfelder M, Buslei R, et al. Multiple tumorous lesions of the pituitary gland. Hormones. 2022;21(4):653–663. https://doi.org/10.1007/s42000-022-00392-9
Gezer E, Selek A, Cetinarslan B, Canturk Z, Tarkun I, Ceylan S. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: a case report. Endocr Regul. 2019;53(4):263–267. https://doi.org/10.2478/enr-2019-0026
Koutourousiou M, Kontogeorgos G, Wesseling P, Grotenhuis AJ, Seretis A. Collision sellar lesions: experience with eight cases and review of the literature. Pituitary. 2010;13(1):8–17. https://doi.org/10.1007/s11102-009-0190-2
Nobusawa S, Nakata S, Hirato J, Kawashima T, Sato K, Fujimaki H, et al. Atypical teratoid/rhabdoid tumor in the sella turcica of an elderly female with a distinct vascular pattern and genetic alterations. Virchows Arch. 2016;469(6):711–715. https://doi.org/10.1007/s00428-016-2017-7
Rubino F, Eichberg DG, Saad AG, Komotar RJ, Ivan ME. Synchronous posterior and anterior pituitary tumors: a case report of a hypothetic paracrine relationship. Asian J Neurosurg. 2023;18(2):377–382. https://doi.org/10.1055/s-0043-1768601
Saeger W, von Schöning J, Flitsch J, Jautzke G, Bergmann M, Hagel C, et al. Co‐occurrence of pituitary neuroendocrine tumors (PitNETs) and tumors of the neurohypophysis. Endocr Pathol. 2021;32(4):473–479. https://doi.org/10.1007/s12022-021-09677-y
Neidert MC, Leske H, Burkhardt JK, Kollias SS, Capper D, Schrimpf D, et al. Synchronous pituitary adenoma and pituicytoma. Hum Pathol. 2016;47(1):138–143. https://doi.org/10.1016/j.humpath.2015.08.017
Barresi V, Simbolo M, Gessi M, Rossi S, Caffo M, Eccher A, et al. Clinical‐pathological, Immunohistochemical, and genetic characterization of a series of posterior pituitary tumors. J Neuropathol Exp Neurol. 2021;80(1):45–51. https://doi.org/10.1093/jnen/nlaa139
Miller MB, Bi WL, Ramkissoon LA, Kang YJ, Abedalthagafi M, Knoff DS, et al. MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma. Oncotarget. 2016;7(24):37054–37063. https://doi.org/10.18632/oncotarget.9244
Sollfrank L, Lettmaier S, Erdmann M, Uslu U. Panniculitis under successful targeted inhibition of the MAPK/ERK signaling pathway in a patient with BRAF V600E‐mutated spindle cell oncocytoma of the pituitary gland. Anticancer Res. 2019;39(7):3955–3959. https://doi.org/10.21873/anticanres.13549
Dawoud FM, Naylor RM, Giannini C, Swanson AA, Meyer FB, Uhm JH. TTF‐1 positive posterior pituitary tumor: limitations of current treatment and potential new hope in BRAF V600E mutation variants. Clin Neurol Neurosurg. 2020;196:106059. https://doi.org/10.1016/j.clineuro.2020.106059
Grenier‐Chartrand F, Barrit S, Racu ML, Luce S, Spitaels J, Sadeghi‐Meibodi N, et al. Dabrafenib monotherapy for a recurrent BRAFV600E‐mutated TTF‐1‐positive posterior pituitary tumor. Acta Neurochir. 2022;164(3):737–742. https://doi.org/10.1007/s00701-022-05109-w
Krokker L, Nyírő G, Reiniger L, Darvasi O, Szücs N, Czirják S, et al. Differentially expressed miRNAs influence metabolic processes in pituitary oncocytoma. Neurochem Res. 2019;44(10):2360–2371. https://doi.org/10.1007/s11064-019-02789-2
Hong CS, Elsamadicy AA, Fisayo A, Inzucchi SE, Gopal PP, Vining EM, et al. Comprehensive genomic characterization of a case of granular cell tumor of the posterior pituitary gland: a case report. Front Endocrinol. 2021;12:762095. https://doi.org/10.3389/fendo.2021.762095
Roncaroli F, Chatterjee D, Giannini C, Pereira M, La Rosa S, Brouland JP, et al. Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF‐1‐positive sellar lesions. Neuropathol Appl Neurobiol. 2020;46(5):493–505. https://doi.org/10.1111/nan.12622
Chen CG, Aldape K, Dhillon KS, Laske DW, Abdullaev Z, Marotta DA, et al. DNA methylation profiling and histologic analysis of sellar TTF‐1‐positive papillary epithelial tumor supports a novel CNS entity. J Neuropathol Exp Neurol. 2022;82(1):96–98. https://doi.org/10.1093/jnen/nlac105
Feng J, Duan Z, Yao K, Gui Q, Liu X, Wang X, et al. Primary papillary epithelial tumor of the sella and posterior pituitary tumor show similar (epi)genetic features and constitute a single neuro‐oncological entity. Neuro Oncol. 2023;25(8):1487–1497. https://doi.org/10.1093/neuonc/noad067
Rima S, Rao S, Nigam P, Kacchara R. Primary papillary epithelial tumor of the sella: a case report of an emerging tumor type. Brain Tumor Pathol. 2024;41(1):30–34. https://doi.org/10.1007/s10014-023-00472-7
Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, et al. DNA methylation‐based classification of central nervous system tumours. Nature. 2018;555(7697):469–474. https://doi.org/10.1038/nature26000
Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, et al. Practical implementation of DNA methylation and copy‐number‐based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018;136(2):181–210. https://doi.org/10.1007/s00401-018-1879-y
Arita K, Sugiyama K, Sano T, Oka H. Atypical teratoid/rhabdoid tumour in sella turcica in an adult. Acta Neurochir. 2008;150(5):491–495 [discussion 496]. https://doi.org/10.1007/s00701-008-1500-y
Moretti C, Lupoi D, Spasaro F, Chioma L, Di Giacinto P, Colicchia M, et al. Sella turcica atypical teratoid/rhabdoid tumor complicated with lung metastasis in an adult female. Clin Med Insights Case Rep. 2013;27(6):177–182. https://doi.org/10.4137/CCRep.S12834
Las Heras F, Pritzker KP. Adult variant of atypical teratoid/rhabdoid tumor: immunohistochemical and ultrastructural confirmation of a rare tumor in the sella tursica. Pathol Res Pract. 2010;206(11):788–791. https://doi.org/10.1016/j.prp.2010.07.004
Nakata S, Nobusawa S, Hirose T, Ito S, Inoshita N, Ichi S, et al. Sellar atypical teratoid/rhabdoid tumor (AT/RT): a clinicopathologically and genetically distinct variant of AT/RT. Am J Surg Pathol. 2017;41(7):932–940. https://doi.org/10.1097/PAS.0000000000000845
Paolini MA, Kipp BR, Sukov WR, Jenkins SM, Barr Fritcher EG, Aranda D, et al. Sellar region atypical teratoid/rhabdoid tumors in adults: clinicopathological characterization of five cases and review of the literature. J Neuropathol Exp Neurol. 2018;77(12):1115–1121. https://doi.org/10.1093/jnen/nly091
Al‐Hussaini M, Dissi N, Souki C, Amayiri N. Atypical teratoid/rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers. Neuropathology. 2016;36(1):17–26. https://doi.org/10.1111/neup.12231
Johann PD, Bens S, Oyen F, Wagener R, Giannini C, Perry A, et al. Sellar region atypical teratoid/rhabdoid tumors (ATRT) in adults display DNA methylation profiles of the ATRT‐MYC subgroup. Am J Surg Pathol. 2018;42(4):506–511. https://doi.org/10.1097/PAS.0000000000001023
Barresi V, Lionti S, Raso A, Esposito F, Cannavò S, Angileri FF. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: a unique description. Neuropathology. 2018;38(3):260–267. https://doi.org/10.1111/neup.12440
Gong L, Chen H, Zhang W, Liu X, Wang Y, Mu X, et al. Primary collision tumors of the sellar region: experience from a single center. J Clin Neurosci. 2022;100:204–211. https://doi.org/10.1016/j.jocn.2022.04.024